DBCCF
Price
$0.10
Change
-$0.00 (-0.00%)
Updated
Aug 28 closing price
Capitalization
56.28M
ELTP
Price
$0.66
Change
+$0.09 (+15.79%)
Updated
Aug 28 closing price
Capitalization
705.55M
Interact to see
Advertisement

DBCCF vs ELTP

Header iconDBCCF vs ELTP Comparison
Open Charts DBCCF vs ELTPBanner chart's image
Decibel Cannabis
Price$0.10
Change-$0.00 (-0.00%)
Volume$51.43K
Capitalization56.28M
Elite Pharmaceuticals
Price$0.66
Change+$0.09 (+15.79%)
Volume$5.9M
Capitalization705.55M
DBCCF vs ELTP Comparison Chart in %
Loading...
DBCCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELTP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DBCCF vs. ELTP commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBCCF is a Hold and ELTP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (DBCCF: $0.10 vs. ELTP: $0.66)
Brand notoriety: DBCCF and ELTP are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: DBCCF: 48% vs. ELTP: 371%
Market capitalization -- DBCCF: $56.28M vs. ELTP: $705.55M
DBCCF [@Pharmaceuticals: Generic] is valued at $56.28M. ELTP’s [@Pharmaceuticals: Generic] market capitalization is $705.55M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DBCCF’s FA Score shows that 0 FA rating(s) are green whileELTP’s FA Score has 1 green FA rating(s).

  • DBCCF’s FA Score: 0 green, 5 red.
  • ELTP’s FA Score: 1 green, 4 red.
According to our system of comparison, both DBCCF and ELTP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DBCCF’s TA Score shows that 4 TA indicator(s) are bullish while ELTP’s TA Score has 4 bullish TA indicator(s).

  • DBCCF’s TA Score: 4 bullish, 4 bearish.
  • ELTP’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, DBCCF is a better buy in the short-term than ELTP.

Price Growth

DBCCF (@Pharmaceuticals: Generic) experienced а +0.93% price change this week, while ELTP (@Pharmaceuticals: Generic) price change was +18.70% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.61%. For the same industry, the average monthly price growth was +12.19%, and the average quarterly price growth was +85.29%.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.61% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELTP($706M) has a higher market cap than DBCCF($56.3M). ELTP has higher P/E ratio than DBCCF: ELTP (28.87) vs DBCCF (3.37). DBCCF YTD gains are higher at: 102.287 vs. ELTP (21.752). DBCCF has higher annual earnings (EBITDA): 19.7M vs. ELTP (1.29M). ELTP has more cash in the bank: 21.7M vs. DBCCF (4.49M). ELTP has less debt than DBCCF: ELTP (6.68M) vs DBCCF (47.1M). ELTP has higher revenues than DBCCF: ELTP (105M) vs DBCCF (92.8M).
DBCCFELTPDBCCF / ELTP
Capitalization56.3M706M8%
EBITDA19.7M1.29M1,530%
Gain YTD102.28721.752470%
P/E Ratio3.3728.8712%
Revenue92.8M105M88%
Total Cash4.49M21.7M21%
Total Debt47.1M6.68M706%
FUNDAMENTALS RATINGS
DBCCF vs ELTP: Fundamental Ratings
DBCCF
ELTP
OUTLOOK RATING
1..100
6378
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
77
Overvalued
PROFIT vs RISK RATING
1..100
9230
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3541
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DBCCF's Valuation (49) in the null industry is in the same range as ELTP (77). This means that DBCCF’s stock grew similarly to ELTP’s over the last 12 months.

ELTP's Profit vs Risk Rating (30) in the null industry is somewhat better than the same rating for DBCCF (92). This means that ELTP’s stock grew somewhat faster than DBCCF’s over the last 12 months.

ELTP's SMR Rating (100) in the null industry is in the same range as DBCCF (100). This means that ELTP’s stock grew similarly to DBCCF’s over the last 12 months.

DBCCF's Price Growth Rating (35) in the null industry is in the same range as ELTP (41). This means that DBCCF’s stock grew similarly to ELTP’s over the last 12 months.

DBCCF's P/E Growth Rating (100) in the null industry is in the same range as ELTP (100). This means that DBCCF’s stock grew similarly to ELTP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DBCCFELTP
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 18 days ago
84%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 23 days ago
88%
Bearish Trend 7 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
DBCCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELTP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRYMF90.412.14
+2.42%
Prysmian S.P.A.
SPRBD7.500.02
+0.27%
Spruce Biosciences, Inc.
BUGDF4.23N/A
N/A
Bumrungrad Hospital Public Co., Ltd.
OBSJF0.35N/A
N/A
Obrascon Huarte Lain Brasil S.A.
CXGEF0.18N/A
N/A
Computer & Technologies Holdings Ltd.

DBCCF and

Correlation & Price change

A.I.dvisor tells us that DBCCF and AYTU have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DBCCF and AYTU's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DBCCF
1D Price
Change %
DBCCF100%
-1.48%
AYTU - DBCCF
21%
Poorly correlated
-0.86%
ESALF - DBCCF
15%
Poorly correlated
N/A
CXXIF - DBCCF
2%
Poorly correlated
-0.93%
CRLBF - DBCCF
2%
Poorly correlated
+4.01%
ELTP - DBCCF
-1%
Poorly correlated
+15.60%
More

ELTP and

Correlation & Price change

A.I.dvisor tells us that ELTP and QNTM have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ELTP and QNTM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELTP
1D Price
Change %
ELTP100%
+15.60%
QNTM - ELTP
24%
Poorly correlated
+2.99%
ECGS - ELTP
15%
Poorly correlated
-6.20%
HKMPF - ELTP
6%
Poorly correlated
N/A
GRUSF - ELTP
5%
Poorly correlated
-3.98%
DBCCF - ELTP
4%
Poorly correlated
-1.48%
More